Use of Psychotropic Medications in Breastfeeding Women: Acute and Prophylactic Treatment

References

• O'Hara M, Swain O. Rates and risk of postpartum depression: A meta-analysis. International Review of Psychiatry 1996; 8: 37–54
   Web of Science ®Google Scholar
• Cox L, Declan M, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. British Journal of Psychiatry 1993; 163: 27–31
   PubMed Web of Science ®Google Scholar
• Cooper PJ, Murray L. Course and recurrence of postnatal depression: Evidence for the specificity of the diagnostic concept. British Journal of Psychiatry 1995; 166: 191–195
   PubMed Web of Science ®Google Scholar
• Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. British Journal of Psychiatry 1987; 150: 662–673
   PubMed Web of Science ®Google Scholar
• Reich T, Winokur G. Postpartum psychoses in patients with manic depressive disease. Journal of Nervous and Mental Disease 1970; 151: 60–68
   PubMed Web of Science ®Google Scholar
• Appleby L, Warner R, Whitton A, Faragher B. A controlled study of fluoxetine and cognitive behavioural counselling in the treatment of postnatal depression. British Medical Journal 1997; 314: 932–936
   PubMed Web of Science ®Google Scholar
• Holden JM, Sagovsky R, Cox JL. Counselling in a general practice setting: Controlled study of health visitor intervention in treatment of postnatal depression. British Medical Journal 1989; 298: 223–226
   PubMed Web of Science ®Google Scholar
• Wickberg B, Hwang CP. Counselling of postnatal depression: A controlled study on a population based Swedish sample. Journal of Affective Disorders 1996; 39: 209–216
   PubMed Web of Science ®Google Scholar
• Murray L, Cooper P. Pospartum depression and child development. Psycholological Medicine 1997; 27: 253–260
   PubMed Web of Science ®Google Scholar
• Oates M. Patients as parents: The risk to children. British Journal of Psychiatry 1997; 170: 22–27
   Web of Science ®Google Scholar
• Kumar R, Hipwell A. Implications for the infant of maternal puerperal psychiatric disorders. Child and Adolescent Psychiatry2nd edn., M Rutter, L Hersov, E Taylor. Blackwell Science, Oxford 1994; 759–775
   Google Scholar
• Scott PD. Parents who kill their children. Medicine, Science and the Law 1973; 13: 120–126
   PubMed Web of Science ®Google Scholar
• Ilett KF, Kristensen JH, Wojnar-Horton RE, Begg EJ. Drug distribution in human milk. Australian Prescriber 1997; 20: 35–40
   Google Scholar
• Isenberg KE, Missouri SL. Excretion of fluoxetine in human breast-milk. Journal of Clinical Psychiatry 1990; 51: 4
   Web of Science ®Google Scholar
• Burch KJ, Wells BG. Fluoxetine/norfluoxetine concentrations in human milk. Paediatrics 1992; 89: 676–677
   PubMed Web of Science ®Google Scholar
• Lester BM, Cucca J, Andreozzi L, et al. Possible association between fluoxetine hydrochloride and colic in an infant. Journal of American Academy of Child and Adolescent Psychiatry 1993; 32: 6
   Web of Science ®Google Scholar
• Taddio A, Ito S, Koren G. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. Journal of Clinical Pharmacology 1996; 36: 42–47
   PubMed Web of Science ®Google Scholar
• Yoshida K, Smith B, Craggs M, Channi Kumar R. Fluoxetine in breast-milk and developmental outcome of breast-fed infants. British Journal of Psychiatry 1998; 172: 175–179
   PubMed Web of Science ®Google Scholar
• Mammen OK, Perel JM, Rudolph G, Foglia JP, Wheeler SB. Sertraline and norsertraline levels in three breastfed infants. Journal of Clinical Psychiatry 1997; 58: 100–103
   PubMed Web of Science ®Google Scholar
• Rohain A. Drug distribution in human milk. Australian Prescriber 1997; 20: 84
   Google Scholar
• Stowe Z, Owens N, Michael N, Emeroff CB. Sertraline and desmethylsertraline in human breast milk and nursing infants. American Journal of Psychiatry 1997; 154: 1255–1260
   PubMed Web of Science ®Google Scholar
• Wisner KL, Wheeler SB. Prevention of recurrent postpartum major depression. Hospital and Community Psychiatry 1994; 45: 1191–1196
   PubMedGoogle Scholar
• Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breast-feeding. American Journal of Psychiatry 1996; 153: 1132–1137
   PubMed Web of Science ®Google Scholar
• Yoshida K, Smith B, Craggs M, Channi Kumar R. Investigation of pharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk. Journal of Affective Disorders 1997; 43: 225–237
   PubMed Web of Science ®Google Scholar
• Buist A, Janson H. Effect of exposure to dothiepin and northiaden in breast milk on child development. British Journal of Psychiatry 1995; 167: 370–373
   PubMed Web of Science ®Google Scholar
• Pons G, Schoerlin MP, Tam YK, et al. Moclobemide excretion in human breast milk. British Journal of Clinical Pharmacology 1990; 29: 27–31
   PubMed Web of Science ®Google Scholar
• Pons G, Rey E, Matheson I. Excretion of psychoactive drugs into breast milk: Pharmacokinetic principles and recommendations. Clinical Pharmacokinetics 1994; 27: 270–289
   PubMed Web of Science ®Google Scholar
• Wiles DH, Orr MW, Kolakowska T. Chlorpromazine levels in plasma and milk of nursing mothers. British Journal of Clinical Pharmacology 1978; 5: 272–273
   PubMed Web of Science ®Google Scholar
• Yoshida K, Smith B, Craggs M, Channi Kumar R. Neuroleptic drugs in breast-milk: A study of pharmacokinetics and of possible adverse effects in breast-fed infants. Psychological Medicine 1998; 28: 81–91
   PubMed Web of Science ®Google Scholar
• Yoshida K, Kumar R. Breast feeding and psychotropic drugs. International Review of Psychiatry 1996; 8: 117–124
   Web of Science ®Google Scholar
• Schou M. Lithium treatment during pregnancy, delivery and lactation: An update. Journal of Clinical Psychiatry 1990; 51: 410–413
   PubMed Web of Science ®Google Scholar
• Mitchell P, Parker G. Treatment of bipolar disorder. Medical Journal of Australia 1990; 155: 488–492
   Web of Science ®Google Scholar
• Chisholm CA, Kuller JA. A guide to the safety of CNS-active agents during breastfeeding. Drug Safety 1997; 17: 127–142
   PubMed Web of Science ®Google Scholar
• McNeil TF. A prospective study of post-partum psychoses in a high-risk group. Acta Psychiatrica Scandinavica 1986; 74: 205–216
   PubMed Web of Science ®Google Scholar
• Cooper PJ, Campbell EA, Day A, Kennerley H, Bond A. Non-psychotic psychiatric disorder after childbirth. A prospective study of prevalence, incidence, course and nature. British Journal of Psychiatry 1988; 152: 799–806
   PubMed Web of Science ®Google Scholar
• Stewart DE, Klompenhouwer JL, Kendell RE, Van H, Ulst AM. Prophylactic lithium in puerperal psychosis. British Journal of Psychiatry 1991; 158: 393–397
   PubMed Web of Science ®Google Scholar
• Austin M-P.V. Puerperal affective psychosis: Is there a case for lithium prophylaxis?. British Journal of Psychiatry 1992; 161: 692–694
   PubMed Web of Science ®Google Scholar
• Cohen LS, Sichel DA, Robertson LM, Heckscher E, Rosenbaum JF. Postpartum prophylaxis for women with bipolar disorder. American Journal of Psychiatry 1995; 152: 1641–1645
   PubMed Web of Science ®Google Scholar
• Wisner KK, Perel JM, Peindl KS, Findling RL, Hanusa BH. Effects of the postpartum period on nortriptyline pharmacokinetics. Psychopharmacology Bulletin 1997; 33: 243–248
   PubMedGoogle Scholar
• Keck PE, McElroy S, Tugrul KC, Bennett JA. Vaproate oral loading in the treatment of acute mania. Journal of Clinical Psychiatry 1993; 54: 305–308
   PubMed Web of Science ®Google Scholar